InnaVirVax Initiates Phase 2 Clinical Trial Evaluating VAC-3S, A Therapeutic Vaccine Used in Combination With Standard Antiretroviral Therapy in Treatment of HIV-Infection December 2, 2013 FINAL_InnaVirVax_VAC3S_WorldAIDS DayDec2013 Share this: